Dabigatran Versus Warfarin in Relation to Renal Function in Patients With Atrial Fibrillation

被引：11
|
作者：
Munoz, Freddy Del-Carpio [1 ]
Yao, Xiaoxi [1 ]
Abraham, Neena S. [1 ]
Bellolio, M. Fernanda [1 ]
Rabinstein, Alejandro A. [1 ]
Asirvatham, Samuel J. [1 ]
McBane, Robert D. [1 ]
Gersh, Bernard J. [1 ]
Shah, Nilay D. [1 ]
Noseworthy, Peter A. [1 ]
机构：
[1] Mayo Clin, Coll Med, Div Cardiovasc Dis, 200 First St SW, Rochester, MN 55905 USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2016年 / 68卷 / 01期
关键词：
EFFICACY; SAFETY;
D O I：
10.1016/j.jacc.2016.04.031
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：129 / 131
页数：4
相关论文
共 50 条
  • [21] THE SAFETY OF ANTICOAGULATION FOR ATRIAL FIBRILLATION WITH DOAC VERSUS WARFARIN IN PATIENTS WITH VARIOUS STAGES OF RENAL FUNCTION
    Makani, Amber
    Saba, Samir
    Jain, Sandeep
    Bhonsale, Aditya
    Marroquin, Oscar
    Mulukutla, Suresh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 322 - 322
  • [22] Frailty and benefit of dabigatran versus warfarin in older adults with atrial fibrillation
    Kim, Dae
    Glynn, Robert
    Avorn, Jerry
    Dejene, Sara
    Schneeweiss, Sebastian
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2018, 27 : 9 - 9
  • [23] Efficacy and safety of dabigatran compared with warfarin in patients with atrial fibrillation in relation to renal function over time-A RE-LY trial analysis
    Hijazi, Ziad
    Hohnloser, Stefan H.
    Oldgren, Jonas
    Andersson, Ulrika
    Connolly, Stuart J.
    Eikelboom, John W.
    Ezekowitz, Michael D.
    Reilly, Paul A.
    Yusuf, Salim
    Wallentin, Lars
    AMERICAN HEART JOURNAL, 2018, 198 : 169 - 177
  • [24] Dabigatran compared to warfarin when given to patients with atrial fibrillation
    不详
    FORMULARY, 2010, 45 (01) : 16 - 16
  • [25] Dabigatran etexilate: An alternative to warfarin for patients with nonvalvular atrial fibrillation
    Scott, Katie A.
    Amirehsani, Karen A.
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2015, 27 (04) : 190 - 196
  • [26] Effectiveness and Safety of Apixaban, Dabigatran, and Rivaroxaban Versus Warfarin in Frail Patients With Nonvalvular Atrial Fibrillation
    Martinez, Brandon K.
    Sood, Nitesh A.
    Bunz, Thomas J.
    Coleman, Craig I.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08):
  • [27] EFFECTIVENESS AND SAFETY OF APIXABAN, DABIGATRAN AND RIVAROXABAN VERSUS WARFARIN IN FRAIL PATIENTS WITH NONVALVULAR ATRIAL FIBRILLATION
    Coleman, Craig I.
    Turpie, Alexander
    Bunz, Thomas J.
    Sood, Nitesh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2018, 71 (11) : 290 - 290
  • [28] Safety of Dabigatran Versus Warfarin for Periprocedural Anticoagulation in Patients Undergoing Ablation for Atrial Fibrillation Reply
    Lakkireddy, Dhanunjaya
    Reddy, Yeruva Madhu
    Di Biase, Luigi
    Natale, Andrea
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2012, 60 (12) : 1119 - 1120
  • [29] Comparative Effectiveness of Dabigatran and Rivaroxaban versus Warfarin in Patients With Non-Valvular Atrial Fibrillation
    Bengtson, Lindsay
    Chen, Lin
    MacLehose, Richard
    Lutsey, Pamela
    Alonso, Alvaro
    CIRCULATION, 2014, 130
  • [30] Insights from the dabigatran versus warfarin in patients with atrial fibrillation (RE-LY) trial
    Khoo, Chee W.
    Lip, Gregory Y. H.
    EXPERT OPINION ON PHARMACOTHERAPY, 2010, 11 (04) : 685 - 687
12345